論文掲載情報（英文）
Matsushima S
Clinical Outcomes after One-day or Two-day Intervals in Conditioning Regimens for allo-HCT. J Pediatr Hematol Oncol 45(3):e378-e383,2023
Yanagi M
Development of nephrotic syndrome during immunosuppressive treatment for aplastic anaemia with monosomy 7 in a 16-year-old boy: A case report. J Paediatr Child Health 59(2):365-367,2023
Sano H
Intralobar Nephroblastomatosis Mimicking Wilms Tumor Treated with Chemotherapy after Removal of the Affected Kidney. Clinical Pediatric Hematology-Oncology 30(1):21-24,2023
Miura M
Temporary reduction of immunosuppression enhances production of anti-S antibody against severe acute respiratory syndrome coronavirus 2 after vaccination in kidney transplant recipients. International Journal of Urology 29(12):1505-1510,2022
Miura M
Initial experience of transurethral ultrasound ablation of the prostate in Asia. BJUI Compass.3(6):405-407,2022
Sano H
Analysis of long-term renal function in patients with malignant solid tumors: Retrospective analysis using the estimated glomerular filtration rate. Pediatrics International.64(1):e15373. doi: 10.1111/ped.15373.
Hori D
Hepatic cirrhosis after hematopoietic stem cell transplantation for neuroblastoma. Pediatrics International.64(1):e15267. doi: 10.1111/ped.15267.
Yanagi M
Early reconstitution of lymphocytes after allogenic hematopoietic stem cell transplantation affects chronic graft-versus-host disease. Pediatrics International.64(1):e15222. doi: 10.1111/ped.15222.
Matsushima S
Colorectal signet-ring cell carcinoma treated with FOLFOX plus panitumumab. Pediatrics International.64(1):e15374. doi: 10.1111/ped.15374.
Matsushima S
Successful treatment of steroid-dependent gastrointestinal acute graft-versus-host disease with mesenchymal stromal cells administered more than 100 days after allo-HCT. Blood Cell Therapy.5(3):27-30,2022
Yoshida S
The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. doi: 10.1038/s41409-022-01843-y.
Imamura M
Hypothesis: can transfer of primary neoplasm-derived extracellular vesicles and mitochondria contribute to the development of donor cell-derived hematologic neoplasms after allogeneic hematopoietic cell transplantation? Cytotherapy.24(12):1169-1180,2022
Hidaka D
New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination. Int J Hematol.115(3):424-427,2022
Ogasawara M
Wilms' tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma. Leukemia＆Lymphoma.63(7):1733-1737,2022
Kobayashi R
Meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin/tazobactam as a 1-h drip infusion four times a day.International Journal of Hematology.113(3):430-435,2021
Kobayashi R
Efficacy of liposomal amphotericin against febrile neutropenia in pediatric patients receiving prophylactic voriconazole.
Pediatrics International.63(5):550-555,2021
Hori D
A survey of hypercalciuria during chemotherapy in acute lymphoblastic leukemia. Pediatrics International 63(8):923-928,2021
Sano H
Comparison of the Efficacy of Piperacillin/Tazobactam and Meropenem,with or without Intravenous Immunoglobulin, as Second-Line Therapy for Febrile Neutropenia: A Prospective,Randomized Study. Clinical Pediatric Hematology-Oncology.28(2):75-83,2021
Ogasawara M
Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial. Ther Apher Dial. 25(4):415-424,2021
Ota S
Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy. Hum Vaccin Immunother. 2021 Dec 17:1-10.